Markets
Stocks
Funds
Sectors
Tools
Treasury & Bonds
Overview
Market News
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
My Portfolio
PIERIS PHARMACEU RG (NQ: PIRS)
6.240 USD  +0.130 (+2.13%)
Official Closing Price  /  Updated: 8:00 PM EDT, May 25, 2018  /  Add to My Watchlist      
View: Quote News
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 498,988
Open 6.050
Bid (Size) 6.000 (200)
Ask (Size) 6.350 (2000)
Prev. Close 6.110
Today's Range 5.990 - 6.330
52wk Range 4.110 - 9.750
Shares Outstanding 53,974,184
Dividend Yield N/A
Performance
YTD
-19.48%
-19.48%
1 Month
-2.95%
-2.95%
3 Month
-27.36%
-27.36%
6 Month
-4.00%
-4.00%
1 Year
+40.22%
+40.22%
Top News
More News
Pieris Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update
Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for cancer, respiratory and... Read More
from GlobeNewswire News Releases
Pieris Pharmaceuticals to Present at 43rd Annual Deutsche Bank Health Care Conference
Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for cancer, respiratory and other diseases,... Read More
from GlobeNewswire News Releases
More News
Read More
Pieris Pharmaceuticals to Host First Quarter 2018 Investor Call and Corporate Update on May 10, 2018
from Marketwired News Releases
Pieris Pharmaceuticals to Host First Quarter 2018 Investor Call and Corporate Update on May 10, 2018
from Marketwired
Investor Expectations to Drive Momentum within Blackbaud, Pieris Pharmaceuticals, Sarepta Therapeutics, Cambrex, Stoneridge, and First Interstate BancSystem — Discovering Underlying Factors of Influen
from GlobeNewswire News Releases
Biotech Stocks' Research Reports Released on Pieris Pharma, Portola Pharma, Protalix BioTherapeutics, and Radius Health
from PR Newswire
Pieris Pharmaceuticals Appoints Ann Barbier, M.D., Ph.D., to its Board of Directors
from Marketwired News Releases
Pieris Pharmaceuticals Appoints Ann Barbier, M.D., Ph.D., to its Board of Directors
from Marketwired
What's Happening with These Biotech Stocks? -- OncoSec Medical, OvaScience, Pacific Biosciences of California, and Pieris Pharma
from PR Newswire
Investors Snatch PIRS 26.7% Cheaper Than Its Secondary Stock Offering
category Stocks
from Market News Video
Pieris Pharmaceuticals Reports Full-Year 2017 Financial Results and Corporate Update
from Marketwired News Releases
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial